Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives

Frederick C Nucifora1, Edgar Woznica1, Brian J Lee1

  • 1Department of Psychiatry and Behavioral Sciences, Johns Hopkins Hospital, 600 N. Wolfe St., Baltimore, MD 21287, USA.

Neurobiology of Disease
|September 1, 2018
PubMed

Insights

Treatment resistant schizophrenia (TRS) remains a challenge, with varied definitions impacting research. This review covers TRS characteristics, treatments like clozapine, and proposes a new consensus definition for advancing research.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Research

Background:

  • Treatment resistant schizophrenia (TRS) affects a significant patient population, characterized by persistent symptoms despite adequate antipsychotic trials.
  • Inconsistent definitions of TRS hinder research reproducibility and clinical consistency.
  • Understanding the clinical, neuroimaging, and neurobiological features of TRS is crucial.

Purpose of the Study:

  • To review the clinical, neuroimaging, and neurobiological characteristics of Treatment Resistant Schizophrenia (TRS).
  • To summarize current and emerging treatment strategies for TRS, including clozapine and augmentation therapies.
  • To present the latest consensus on defining TRS and discuss future research directions.

Main Methods:

  • Literature review of clinical studies, neuroimaging research, and neurobiological investigations related to TRS.
  • Analysis of pharmacological (clozapine, augmentation) and non-pharmacological (ECT, TMS, DBS, psychotherapy) treatment modalities.
  • Evaluation of proposed consensus criteria for defining TRS.

Main Results:

  • TRS exhibits distinct clinical, neuroimaging, and neurobiological profiles.
  • Clozapine is the established first-line treatment, with various augmentation strategies showing promise.
  • A new consensus definition for TRS has been proposed to improve research consistency.

Conclusions:

  • Standardizing the definition of TRS is essential for advancing research and clinical practice.
  • A multimodal treatment approach, including clozapine and augmentation, is key for managing TRS.
  • Future research should explore TRS as a potential distinct subtype of schizophrenia.

Related Concept Videos

Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
633
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
980
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
626
Psychodynamic Perspectives on Personality01:27

Psychodynamic Perspectives on Personality

The psychodynamic perspective in psychology asserts that most personality functions operate unconsciously, outside of awareness. This means that the motives and emotions driving behavior often remain hidden, automatically buried in the unconscious mind as a defense mechanism to shield us from psychological distress. According to this theory, the unconscious mind contains thoughts, memories, and emotions that are too disturbing to face directly.
Psychodynamic theorists argue that unconscious...
1.6K